L-Histidine for Joint Pain Relief

Research suggests that L-histidine is consistently identified as a metabolite found at lower levels in the blood of rheumatoid arthritis patients compared to healthy individuals, a pattern noted across a 2024 meta-analysis of 49 studies and a 2020 systematic review, as well as a 2020 narrative review in which histidine appeared repeatedly across multiple RA studies as a potentially meaningful marker of disease. Studies indicate that histidine also appears among the metabolites that differ between rheumatoid arthritis and osteoarthritis when joint fluid is analyzed directly, pointing to its relevance in distinguishing inflammatory from degenerative joint conditions. However, the available evidence is largely observational and diagnostic in nature — focused on identifying histidine as a potential biomarker rather than testing it as a therapeutic intervention for joint pain — and the one clinical study included here examined a sulphasalazine derivative rather than histidine directly. Overall, the body of evidence is preliminary and mixed in focus, and no strong conclusions can be drawn about whether supplementing with L-histidine would meaningfully relieve joint pain in humans based on current published research.